Norway’s Wealth Fund Opposes Board Changes at Novo Nordisk
Norway’s wealth fund is opposing changes to Novo Nordisk’s board.
Norway’s wealth fund is opposing changes to Novo Nordisk’s board.
Super Micro faces skepticism despite a recent rating upgrade.